Spontaneous cellular and humoral tumor antigen responses in patients with uveal melanoma

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Melanoma research

• Publication date

  2015-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/CMR.0000000000000207PMID 26397048
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses

  2013cited by this paper
• Multiple primary cutaneous melanomas: recent studies highlight features associated with more indolent behaviour.

  2013cited by this paper
• Tumours associated with BAP1 mutations

  2013cited by this paper
• Differential expression of fourteen proteins between uveal melanoma from patients who subsequently developed distant metastases versus those who did Not.

  2012cited by this paper
• Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism array.

  2012cited by this paper
• Optimization and qualification of a multiplex bead array to assess cytokine and chemokine production by vaccine-specific cells.

  2012cited by this paper
• Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma

  2011cited by this paper
• Uveal melanoma: trends in incidence, treatment, and survival.

  2011cited by this paper
• Identification of Autoantibodies for α and γ—Enolase in Serum from a Patient with Melanoma

  2011cited by this paper
• Identification of melanoma antigens using a Serological Proteome Approach (SERPA).

  2010cited by this paper
• Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas

  2010cited by this paper
• Genetics of Uveal Melanoma and Cutaneous Melanoma: Two of a Kind?

  2010cited by this paper
• Proteome Serological Determination of Tumor-Associated Antigens in Melanoma

  2009cited by this paper
• Autoantibodies against bestrophin in a patient with vitelliform paraneoplastic retinopathy and a metastatic choroidal malignant melanoma.

  2008cited by this paper
• CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

  2008cited by this paper
• Autoantibodies to tumor‐associated antigens: reporters from the immune system

  2008cited by this paper
• Mitochondrial DNA sequence variants in epithelial ovarian tumor subtypes and stages

  2007cited by this paper
• Biomarker discovery from uveal melanoma secretomes: identification of gp100 and cathepsin D in patient serum.

  2007cited by this paper
• Human T cell responses against melanoma.

  2006cited by this paper
• Immune Monitoring of T-Cell Responses in Cancer Vaccine Development

  2006cited by this paper
• Proteome analysis of human lung squamous carcinoma

  2006cited by this paper
• Tumor Antigen Expression in Melanoma Varies According to Antigen and Stage

  2006cited by this paper
• Proteomics-based Identification of Human Acute Leukemia Antigens That Induce Humoral Immune Response*

  2005cited by this paper
• Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.

  2005cited by this paper
• CXC Chemokine Receptor 3 Expression by Activated CD8+ T cells Is Associated with Survival in Melanoma Patients with Stage III Disease

  2004cited by this paper
• On the Role of Melanoma-Specific CD8+ T-Cell Immunity in Disease Progression of Advanced-Stage Melanoma Patients

  2004cited by this paper
• Human mena protein, a serex‐defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T‐cell immune response

  2004cited by this paper
• Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccine.

  2003cited by this paper
• Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries

  2003cited by this paper
• Identification of metabolic enzymes in renal cell carcinoma utilizing PROTEOMEX analyses.

  2003cited by this paper
• Association of HLA class I and class II antigen expression and mortality in uveal melanoma.

  2001cited by this paper
• Immunity against cancer: lessons learned from melanoma.

  2001cited by this paper
• Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

  2000cited by this paper
• Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

  2000cited by this paper
• Induction of tyrosinase‐reactive T cells by treatment with dacarbazine, cisplatin, interferon‐alpha ± interleukin‐2 in patients with metastatic melanoma

  1999cited by this paper
• Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression.

  1999cited by this paper
• A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens

  1998cited by this paper
• Recognition of melanoma-associated peptides by peripheral blood mononuclear cells of ocular melanoma patients.

  1998cited by this paper
• Expression of MAGE, gp100 and tyrosinase genes in uveal melanoma cell lines

  1998cited by this paper
• Antibody responses to melanoma/melanocyte autoantigens in melanoma patients.

  1998cited by this paper
• Uveal melanomas contain antigenically specific and non-specific infiltrating lymphocytes.

  1998cited by this paper
• Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.

  1997cited by this paper
• Infrequent expression of the MAGE gene family in uveal melanomas

  1996cited by this paper
• MHC antigens in human melanomas.

  1991cited by this paper
• Predominant expression of T cell receptor V alpha 7 in tumor-infiltrating lymphocytes of uveal melanoma.

  1990cited by this paper
• Phenotypic dynamics of tumor progression in human malignant melanoma

  1985cited by this paper

• Divergent local and systemic antitumor response in primary uveal melanomas

  2024cites this paper
• Proteomics of Primary Uveal Melanoma: Insights into Metastasis and Protein Biomarkers

  2021cites this paper
• B cells and antibody production in melanoma

  2018cites this paper
• Immunotherapy for Uveal Melanoma.

  2017cites this paper
• The crossroads between cancer immunity and autoimmunity: antibodies to self antigens.

  2017cites this paper
• Alpha-Enolase (ENO1), a potential target in novel immunotherapies.

  2017cites this paper
• A multireferral centre retrospective cohort analysis on the experience in treatment of metastatic uveal melanoma and utilization of sequential liver-directed treatment and immunotherapy

  2017cites this paper
• Advances in Proteomic Techniques for Cytokine Analysis: Focus on Melanoma Research

  2017cites this paper